Supriya Lifescience Limited has informed the Exchange about Schedule of meet
SUPRIYA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Supriya Lifescience Limited has informed the exchanges about a scheduled earnings call on Thursday, May 28, 2026 at 11:00 AM IST to discuss the company's operational and financial performance for Q4 FY26 (quarter and year ended March 31, 2026). The company has invited investors to the call where key management, including Executive Chairman Dr. Satish Wagh, Managing Director Dr. Saloni Wagh, and CFO Krishna Raghunathan, will be present. The filing is made pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. An investor presentation will be shared with the exchanges separately. The call access details including dial-in numbers and a pre-registration link were enclosed with the notice.
This is a routine regulatory disclosure notifying investors of an upcoming earnings call. The announcement signals that Q4 and full-year FY26 results are imminent, and shareholders can expect financial details and management commentary shortly after May 28, 2026.